168 related articles for article (PubMed ID: 6839994)
1. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
[TBL] [Abstract][Full Text] [Related]
2. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
[TBL] [Abstract][Full Text] [Related]
3. HLA, anti-DNA, and complement in myasthenia gravis.
Christiansen FT; Houliston JB; Dawkins RL
Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetics of experimental autoimmune myasthenia gravis.
Christadoss P
Crit Rev Immunol; 1989; 9(4):247-78. PubMed ID: 2679661
[TBL] [Abstract][Full Text] [Related]
5. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
6. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
[TBL] [Abstract][Full Text] [Related]
7. [HLA and myasthenia. Subdivision in 3 categories].
Elchidiac A; Lepage V; Berrih S; Colombani J; Degos L
Pathol Biol (Paris); 1985 Jan; 33(1):50-4. PubMed ID: 3871932
[TBL] [Abstract][Full Text] [Related]
8. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
9. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
10. Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen.
Whittingham S; Mathews JD; Schanfield MS; Matthews JV; Tait BD; Morris PJ; Mackay IR
Clin Exp Immunol; 1980 Apr; 40(1):8-15. PubMed ID: 6930337
[TBL] [Abstract][Full Text] [Related]
11. Gm allotypes in Swedish myasthenia gravis patients.
Smith CI; Grubb R; Hammarström L; Matell G
J Immunogenet; 1983 Feb; 10(1):1-9. PubMed ID: 6601678
[TBL] [Abstract][Full Text] [Related]
12. Correlation between acetylcholine receptor antibody titer and HLA-B8 and HLA-DRw3 antigens in myasthenia gravis.
Keesey J; Naeim F; Lindstrom J; Zeller E; Herrmann C; Walford R
Trans Am Neurol Assoc; 1978; 103():188-90. PubMed ID: 757055
[No Abstract] [Full Text] [Related]
13. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
[TBL] [Abstract][Full Text] [Related]
14. Gm allotypes in myasthenia gravis.
Nakao Y; Matsumoto H; Miyazaki T; Nishitani H; Ota K; Fujita T; Tsuji K
Lancet; 1980 Mar; 1(8170):677-80. PubMed ID: 6103092
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and Gm markers.
Smith CI; Norberg R; Möller G; Lönnqvist B; Hammarström L
Eur Neurol; 1989; 29(3):128-34. PubMed ID: 2659367
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
[TBL] [Abstract][Full Text] [Related]
17. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
Niks EH; Kuks JB; Roep BO; Haasnoot GW; Verduijn W; Ballieux BE; De Baets MH; Vincent A; Verschuuren JJ
Neurology; 2006 Jun; 66(11):1772-4. PubMed ID: 16769963
[TBL] [Abstract][Full Text] [Related]
18. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
Brocke S; Brautbar C; Steinman L; Abramsky O; Rothbard J; Neumann D; Fuchs S; Mozes E
J Clin Invest; 1988 Dec; 82(6):1894-900. PubMed ID: 2461962
[TBL] [Abstract][Full Text] [Related]
19. Association of Km3 allotype with increased serum levels of autoantibodies against muscle acetylcholine receptor in myasthenia gravis.
Dondi E; Gajdos P; Bach JF; Garchon HJ
J Neuroimmunol; 1994 May; 51(2):221-4. PubMed ID: 8182118
[TBL] [Abstract][Full Text] [Related]
20. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
Garlepp MJ; Dawkins RL; Christiansen FT
Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
